12-Year within-wound study of the effectiveness of custom pressure garment therapyENGRAV, L. H; HEIMBACH, D. M; RIVARA, F. P et al.Burns. 2010, Vol 36, Num 7, pp 975-983, issn 0305-4179, 9 p.Article

Analytic performance of two automated nonpretreatment digoxin immunoassaysDE, B. K; BOOTH, D. D; MAGEE, P. J et al.Therapeutic drug monitoring. 1999, Vol 21, Num 1, pp 123-128, issn 0163-4356Article

Reconstruction of foot burn contractures in childrenALISON, W. E; MOORE, M. L; REILLY, D. A et al.The Journal of burn care & rehabilitation. 1993, Vol 14, Num 1, pp 34-38, issn 0273-8481Conference Paper

A novel facer for PIR/PUR boardstockLYNCH, J. J; MOORE, M. L; RANDALL, D et al.Cellular polymers. 1991, Vol 10, Num 2, pp 117-131, issn 0262-4893, 15 p.Article

Potent vasopressin antagonists lacking the proline residue at position 7EL-FEHAIL ALI, F; BRYAN, W; STASSEN, F. L et al.Journal of medicinal chemistry (Print). 1986, Vol 29, Num 6, pp 984-988, issn 0022-2623Article

Comparison of four commercial urinary albumin (microalbumin) methods : Implications for detecting diabetic nephropathy using random urine specimensROBERTS, W. L; CALCOTE, C. B; COOK, C. B et al.Clinica chimica acta. 1998, Vol 273, Num 1, pp 21-33, issn 0009-8981Article

Industry, ethics, and general medicine : Workshop No. 5MACKAY, C; MURPHY, P. D; WORSHAM, G. F et al.Cancer. 1997, Vol 80, Num 3, issn 0008-543X, p. 635, SUPConference Paper

A check on rational drug design : crystal structure of a complex of human immunodeficiency virus type 1 protease with a novel γ-turn mimetic inhibitorHOOG, S. S; BAOGUANG ZHAO; ABDEL-MEGUID, S. S et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 17, pp 3246-3252, issn 0022-2623Article

Structure-activity relationships of novel vasopressin antagonists containing C-terminal diaminoalkanes and (aminoalkyl)guanidinesCALLAHAN, J. F; ASHTON-SHUE, D; STASSEN, F. L et al.Journal of medicinal chemistry (Print). 1989, Vol 32, Num 2, pp 391-396, issn 0022-2623, 6 p.Article

Design, synthesis, and biological activity of a peptide mimic of vasopressinBRYAN, W. M; HEMPEL, J. C; HUFFMAN, W. F et al.Journal of medicinal chemistry (Print). 1988, Vol 31, Num 4, pp 742-744, issn 0022-2623Article

Vasopressin antagonist analogs modified at position 7MOORE, M. L; GREENE, H; ASHTON-SHUE, D et al.International journal of peptide & protein research. 1986, Vol 28, Num 4, pp 379-385, issn 0367-8377Article

Novel vasopressin analogues that help define a minimum effective antagonist pharmacophoreHUFFMAN, W. F; ALI, F. E; STASSEN, F. L et al.Journal of medicinal chemistry (Print). 1985, Vol 28, Num 12, pp 1759-1760, issn 0022-2623Article

Dexter®: A tool to facilitate impairment ratingsMOORE, M. L; ENGRAV, L. H; VEDDER, N. B et al.The Journal of burn care & rehabilitation. 2001, Vol 22, Num 6, pp 397-400, issn 0273-8481Conference Paper

A new tool to measure pressure under burn garmentsMANN, R; YEONG, E. K; MOORE, M. L et al.The Journal of burn care & rehabilitation. 1997, Vol 18, Num 2, pp 160-163, issn 0273-8481Conference Paper

Inactivation of HIV-1 protease by a tripeptidyl epoxideGRANT, S. K; MOORE, M. L; FAKHOURY, S. A et al.Bioorganic & medicinal chemistry letters. 1992, Vol 2, Num 11, pp 1441-1445Article

Chromophoric peptide substrates for the spectrophotometric assay of HIV-1 proteaseTOMASZEK, T. A. JR; MAGAARD, V. W; BRYAN, H. G et al.Biochemical and biophysical research communications (Print). 1990, Vol 168, Num 1, pp 274-280, issn 0006-291XArticle

Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic proteaseMEEK, T. D; DAYTON, B. D; METCALF, B. W et al.Proceedings of the National Academy of Sciences of the United States of America. 1989, Vol 86, Num 6, pp 1841-1845, issn 0027-8424Article

A minor modification of residue 1 in potent vasopressin antagonists dramatically reduces agonist activityHUFFMAN, W. F; ALBRIGHTSON-WINSLOW, C; SCHMIDT, D. B et al.Journal of medicinal chemistry (Print). 1989, Vol 32, Num 4, pp 880-884, issn 0022-2623, 5 p.Article

A comparison of women in and out of a prematurity prevention project in a North Carolina perinatal care regionBUESCHER, P. A; MEIS, P. J; ERNEST, J. M et al.American journal of public health (1971). 1988, Vol 78, Num 3, pp 264-267, issn 0090-0036Article

Dicarbavasopressin antagonist analogues exhibit reduced in vivo agonist activityMOORE, M. L; ALBRIGHTSON, C; SORENSON, E et al.Journal of medicinal chemistry (Print). 1988, Vol 31, Num 8, pp 1487-1489, issn 0022-2623, 3 p.Article

Trauma registry databases : A comparison of data abstraction, interpretation, and entry at two level I trauma centersOWEN, J. L; BOLENBAUCHER, R. M; MOORE, M. L et al.The Journal of trauma. 1999, Vol 46, Num 6, pp 1100-1104, issn 0022-5282Conference Paper

The prevalence of domestic violence among women seeking abortionGLANDER, S. S; MOORE, M. L; MICHIELUTTE, R et al.Obstetrics and gynecology (New York. 1953). 1998, Vol 91, Num 6, pp 1002-1006, issn 0029-7844Article

A convenient synthesis of the conformationally constrained amino acid 5,5-dimethylprolineMAGAARD, V. W; SANCHEZ, R. M; BEAN, J. W et al.Tetrahedron letters. 1993, Vol 34, Num 3, pp 381-384, issn 0040-4039Article

A novel constrained reduced-amide inhibitor of HIV-1 protease derived from the sequential incorporation of γ-turn mimetics into a model substrateNEWLANDER, K. A; CALLAHAN, J. F; MOORE, M. L et al.Journal of medicinal chemistry (Print). 1993, Vol 36, Num 16, pp 2321-2331, issn 0022-2623Article

Water uptake and loss via the urosome in terrestrial talitrid amphipods (Crustacea : Amphipoda)MOORE, M. L; RICHARDSON, A. M. M.Journal of natural history. 1992, Vol 26, Num 1, pp 67-77, issn 0022-2933Article